Chipmaker Rout & Oil Plunge Shake Markets; AI Health Deals

No qualifying small-to-medium practice acquisition or group-practice sale appeared in this week’s healthcare candidates. Instead, the strongest deal-adjacent activity centered on venture funding rounds for healthcare technology and services companies. The most notable rounds are detailed below.

Flourish Health closes $26M round for youth mental health. Flourish Health is a startup delivering intensive in-home mental healthcare to children and young adults with serious, complex behavioral health needs. It secured $26 million in new funding. The round is intended to scale the company’s care model. That model is designed to serve patients who typically fall between inpatient and traditional outpatient settings. No lead investor or valuation was disclosed.

Candid Health raises $120M for AI revenue cycle platform. Candid Health closed a $120 million Series D round. The company will use it to expand its artificial-intelligence-powered revenue cycle management (RCM) platform. Sixth Street Growth led the round. Oak HC/FT, 8VC, and Y Combinator also participated. Candid targets the prior-authorization and claims-processing burdens that remain a persistent administrative drag across independent and group practices.

Crystalys Therapeutics adds $130M for gout drug trials. Crystalys Therapeutics secured an additional $130 million. The funding supports pivotal clinical testing of dotinurad, its candidate drug for gout. The company describes gout as an inflammatory condition with few treatment options. Dotinurad shares a mechanism of action with a molecule that Sobi previously added to its pipeline through a $950 million acquisition. That connection lends competitive context to the raise.

A volatile week in global markets is defined by several forces. Oil prices dropped sharply, and semiconductor stocks continued to sell off. Fresh geopolitical uncertainty tied to the US-Iran conflict added to the strain. Its spillover effects reached energy, luxury goods, and investor sentiment.

Chipmakers drag US stocks lower for a third consecutive session. US equities erased an early rally on Monday as chipmakers extended their losing streak. The Philadelphia Semiconductor Index headed toward its third straight session of declines. The selling reflects growing scrutiny of AI infrastructure spending. Investors are asking whether the largest spenders can justify the scale of their investments. That theme is gaining momentum across financial commentary. Separately, S&P Global Ratings recently downgraded Oracle’s long-term issuer credit rating to BBB-, just one notch above junk status. It cited the company’s massive data center and on-site power spending.

Oil sinks as the US pauses strikes on Iran. Crude oil prices fell sharply after the United States paused nearly two weeks of daily military strikes against Iran. The pause eased the immediate supply-disruption premium built into markets. Corn and soybean futures also dropped on the news. Both recorded their steepest single-session declines in months. However, traders remain on edge. Satellite imagery showed smoke at multiple Saudi oil facilities over the prior 48 hours, attributed to attacks by Iran-backed militias. As a result, the medium-term supply outlook stays uncertain. President Trump said he remains prepared to order a return to expanded military operations if diplomatic talks fail.

LVMH fashion unit squeezed by Middle East conflict. LVMH reported that its flagship fashion and leather goods division barely returned to growth last quarter. The division is home to Louis Vuitton and Dior. It was its first positive reading in nearly two years. The Financial Times attributed the muted recovery partly to the Iran conflict deterring wealthy shoppers. Even so, the Dior brand showed individual signs of a rebound. The result underscores how geopolitical instability is now rippling directly into consumer spending at the luxury tier.

New Fed chief and the rate-hike question. Market participants are closely watching the new Federal Reserve chair’s communications approach. The European Central Bank held rates steady last week. ECB president Christine Lagarde cautioned against over-interpreting rapid swings in energy prices while the Middle East conflict remains unresolved. The key question for the Fed is how a surprise rate move would be read. Would markets see it as a deliberate signal or as reactive confusion? Analysts note that recent decades’ surprise moves were reserved for genuine emergencies, not routine recalibration.

Jersey Mike’s IPO draws outsized demand. The Jersey Mike’s Subs initial public offering attracted demand for more than ten times the available shares. The pricing was expected on Wednesday, according to people familiar with the matter. The oversubscription signals that appetite for consumer brand IPOs remains strong. That holds even amid broader equity market turbulence driven by tech and energy volatility.